Day: 2025-03-24

香港, 2025年3月24日 - (亞太商訊 via SeaPRwire.com) - 泛遠國際控股集團有限公司（上市編號：2516，下稱「泛遠國際」；連同其附屬公司，統稱「泛遠國際」或「本集團」）欣然宣佈，本集團間接全資附屬公司杭州泛遠國際物流有限公司（「杭州泛遠」）近日成功加入亞馬遜服務商網絡（「亞馬遜SPN」），為亞馬遜平台賣家提供跨境物流服務。這不僅標誌着本集團綜合能力與服務品質得到全球電商巨頭亞馬遜的認可，同時亦有力推動本集團之跨境電商全球化佈局進程，為集團跨境物流業務的可持續發展奠定堅實基礎。亞馬遜SPN是亞馬遜針對賣家尋找服務商難、同類服務商難對比、溝通週期長等痛點，推出的「一站式跨境解決方案」工具，能幫助賣家快速找到合適的服務商並建立聯繫。其涵蓋包括物流、海外倉、合規稅務在內的8大服務板塊，提供逾30種服務類型，並覆蓋19大亞馬遜海外站點，高效連接賣家與服務商，最終協助賣家達成跨境出海之目標。選定為亞馬遜SPN需經過多維度、嚴苛的資質審核，對認證服務商的服務能力、運營效率、客戶口碑、合規性及品牌影響力均有高標準的要求。泛遠國際作為中國知名的跨境電商物流服務商，擁有廣泛的服務網點及供應商網絡，可為客戶提供多項靈活可靠的跨境配送選項，並在市場上積累良好口碑。是次本集團附屬成功通過亞馬遜各項嚴苛審核，最終成為亞馬遜SPN的認證服務商。這不僅是亞馬遜平台對本集團跨境電商服務能力和卓越運營管理水平的高度認可，更為本集團深化全球佈局注入強勁動力。本集團將透過亞馬遜SPN平台積極開拓海外市場，與全球范圍內的新興客戶建立深度合作關係，並致力於以穩、快、優的跨境物流綜合服務體系，滿足不同國家和地區客戶的多樣化需求，為更多企業順利出海保駕護航。泛遠國際控股集團有限公司主席兼執行董事王泉先生表示：「今次有集團附屬公司成功加入亞馬遜服務商網絡，我們既驚喜又榮幸。這是繼阿里巴巴國際站後，又一全球知名跨境電商平台對本集團於跨境物流領域多年深耕與卓越能力的充分肯定。此次成為亞馬遜服務商有望為本集團帶來更多優質客戶資源與業務機會，同時亦將進一步深化本集團在跨境電商的全球化佈局。展望未來，本集團將積極把握市場機遇，深度整合物流網絡資源，持續為客戶提供更高效便捷的跨境物流服務。同時，本集團亦將繼續深化大平台戰略合作，重點拓展與主流跨境電商平台的深度合作，進一步拓展中小直客，助力更多企業出海。」有關泛遠國際控股集團有限公司（股份代號：2516.HK）泛遠國際控股集團有限公司於2023年12月在香港聯交所主板掛牌上市，為中國知名的跨境電子商務物流服務供應商，主要提供端到端跨境配送服務、貨運代理服務以及其他物流服務，致力打造穩、快、優的跨境電子商務物流服務體系。本集團作為中國（杭州）跨境電子商務綜合試驗區首批試點企業，擁有創新的自研物流運輸系統，採用直營網點模式，網點遍佈中國主要貿易中心，尤其聚焦於長江三角洲及粵港澳大灣區。本集團設有30多個境內網點，1,100多家供應商網路，服務覆蓋全球超過220多個國家和地區，向客戶提供多項靈活可靠的跨境配送選項及定制化供應鏈解決方案。有關杭州泛遠國際物流有限公司杭州泛遠國際物流有限公司為本集團全資附屬公司，主營國際海運、國際空運、國際快件代理業務、跨境電子商務供應鏈及全球物流倉儲整體解決方案等服務。公司秉承「以人為本，傾力親為」的宗旨，致力於打造以涵蓋國際貨物運輸所有業務門類的操作平台為核心的，集倉儲、分撥、配送、物流方案解決為一體的，以跨境物流和全球倉儲服務為基礎的一站式集成物流解決方案供應商。 Copyright 2025 亞太商訊 via SeaPRwire.com.

HONG KONG, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - Dida Inc. (“Dida” or the “Company”, Stock Code: 02559.HK), a leading technology-driven mobility platform, announced the audited consolidated annual results for the year ended December 31, 2024.Financial Highlights:- Revenue was RMB787.2 million for the year ended December 31, 2024, compared to RMB815.1 million for the year ended December 31, 2023.- Gross profit was RMB567.0 million for the year ended December 31, 2024, compared to RMB605.4 million for year ended December 31, 2023.- Net profit increased by 234.4% from RMB300.4 million for year ended December 31, 2023 to RMB1,004.3 million for the year ended December 31, 2024.- Adjusted net profit (non-IFRS measure) was RMB211.4 million for the year ended December 31, 2024, compared to RMB225.6 million for the year ended December 31, 2023.Operation Highlights:- Gross transaction value amounted to RMB7.4 billion and total number of orders reached 119.1 million for the year ended December 31, 2024.- Registered users reached over 372 million as of December 31, 2024- Certified private car owners reached 18.9 million, an increase of 21.4% year-on-yearBusiness OutlookCarpooling marketplace businessThe Company believes carpooling in China is still at its early stage of development, with significant market demand yet to be fully released and the benefits of carpooling not fully recognized by the public. At the same time, the Company notices a year-on-year increase in the demand for carpooling. In 2024, the number of passengers who placed orders surged 34.3% year-over-year, driven by robust demand in lower tier cities. Riders on the platform can access low-cost mobility options and enjoy quality experience. Private car owners can save money on gas and tolls by sharing traveling expenses with riders. Carpooling also brings about numerous societal benefits, such as reducing carbon emissions and mitigating traffic congestion. In the future, the Company will seek more robust, healthier, and suitable transportation capacity and a broader user base through multiple approaches. The Company will establish strong collaborations with third-party platforms to expedite the growth initiatives. In the lower-tier cities, the Company will drive growth through the conversion of private domain traffic, the dissemination of a “low-price” mindset, and the optimization of mini-program functionalities. The Company will continue to fine-tune the algorithms for precise route matching to enhance driver retention. Furthermore, the Company will explore various scalable carpooling scenarios, such as employee commuting and student travel to and out of college campuses, to expand the user base. For the driver side, the Company will also encourage more diversified demands to provide better travel experiences, especially for those looking for better ride compatibility. Moving forward, the Company will continue to refine the station based carpooling model to better meet user needs by offering more compatible and cost effective options.Taxi businessIn selected cities where the Company has already entered into strategic cooperation agreements, the Company will closely work with all relevant stakeholders, including local authorities, taxi industry associations, taxi companies, and taxi drivers to implement its strategy for smart taxi services. Several cities are considering changing traditional fixed-price models for taxi riding to dynamic pricing in response to competition from ride-hailing. The Company is leveraging this opportunity to provide smart taxi service solutions tailored to these cities, which includes technologies and systems to support the implementation of dynamic pricing.For the full announcement of Dida for the annual results ended December 31, 2024, please visitt: https://manager.wisdomir.com/files/594/2025/0321/20250321213001_91138480_en.pdfAbout Dida Inc.Dida Inc. (“Dida” or the “Company”, Stock Code: 02559.HK) is a leading technology-driven mobility platform in China. The Company creates more transit capacity with less environmental impact by providing carpooling marketplace services to pair up riders with private car owners if they are heading in similar directions at compatible times. It also provides smart taxi services, aiming to improve the efficacy and efficiency of relevant stakeholders in the taxi industry in China. Dida makes the mobility ecosystem greener and more efficient, and each trip experience warm and enjoyable.Forward-Looking StatementsThis press release contains forward-looking statements relating to the business outlook, forecast business plans and growth strategies of the Company. These forward-looking statements are based on information currently available to the Company and are stated herein on the basis of the outlook at the time of this press release. They are based on certain expectations, assumptions and premises, some of which are subjective or beyond the control. These forward-looking statements may prove to be incorrect and may not be realized in future. Underlying the forward-looking statements is a large number of risks and uncertainties. Further information regarding these risks and uncertainties is included in the other public disclosure documents on the corporate website. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - Q P Group Holdings Limited (“Q P Group” or the “Group”; Stock code: 1412), a paper product manufacturing and printing services provider, today announced its annual results for the year ended 31 December 2024 (“FY2024” or the “Reporting Period”).In FY2024, the Group achieved revenue of approximately HK$1,210.9 million, representing a year-on-year increase of approximately 16.5%, driven by increased demand from its original equipment manufacturer (“OEM”) and web sales customers. Bolstered by continuous improvements in operational and production efficiency, profit attributable to the equity holders of the Company surged approximately 61.2% to approximately HK$129.1million.The Board of Directors has proposed a final dividend of HK11.0 cents per share (FY2023: HK8.0 cents) for FY2024. Together with the interim dividend of HK3.0 cents (FY2023: HK2.0 cents) already paid, the total dividend for FY2024 will be HK14.0 cents per share (FY2023: HK10.0 cents).Business ReviewDuring the Reporting Period, the Group remained highly focused on steady business expansion and optimisation of operations, successfully capturing new business opportunities driven by rising demand for its major OEM customers’ products. Additionally, the Group made steady progress in diversifying its business across various product lines. Leveraging strengths in product development, production know-how and operation standards for trading cards production, it cultivated business relationships with an industry-leading global trading card company and various publishers in China. During the Reporting Period, the Group’s OEM sales reached approximately HK$984.8 million, up approximately 16.4% from approximately HK$845.8 million for FY2023.In terms of web sales business, riding on the well-established market position, enhanced customer experience and effective cost-saving measures, the Group’s web sales achieved steady growth during the Reporting Period. Q P Market Network (“QPMN”), our recently launched business-to-business-to-consumer (B2B2C) e-commerce platform, also made ongoing efforts to enhance its website’s infrastructure and functionality, and successfully built relationships with business partners from all over the world. In FY2024, the Group’s web sales amounted to approximately HK$226.1 million, representing a growth of approximately 16.9% as compared with approximately HK$193.4 million for FY2023.In respect of operations, the Vietnam plant commenced full-scale operations during the Reporting Period, becoming a crucial production hub for the Group. In September 2024, the Group entered into a construction agreement with a contractor for the construction works in relation to the expansion of the Vietnam plant.ProspectsLooking ahead, the Group will stay focused on steady business expansion and operational optimisation. It aims to strengthen its OEM solutions by innovating in product structural design, printing and finishing techniques, and new material utilisation. To capitalise on the booming trading card games market, the Group will actively participate in relevant trade shows to enhance market penetration and position itself to seize emerging opportunities.The development of QPMN remains the Group’s key growth strategy in web sales business in the long run. The Group will focus on enriching its e-commerce solutions for product customisation, expanding its product range and enhancing its integration with popular e-commerce platforms, in order to better align with the market standard and expectations of business partners. For the Original Brand Manufacturer (“OBM”) business, the brand’s dedicated team has formulated a series of online and offline approaches, aiming to progressively diversify the brand’s sales channels, enlarge customer base, broaden market presence and grow the customer base. Besides playing cards, the brand will explore the market potential of other products such as trading card games, board games, and tarot decks to promote brand awareness and expand revenue streams.The Group will continue to optimise production operations, with the expansion of its Vietnam production base progressing on schedule and expected to commence operations in the third quarter of 2025. This strategic expansion will enable the Group to develop a more comprehensive supply chain in Vietnam and diversify the potential operational risks arising from geopolitical factors. On the other hand, following the recent milestone of achieving the certification of 2i level of Industry 4.0 maturity, the Group is committed to advancing its digital transformation through improvement in utilisation of operational data and scaling up the application of smart operations across more production lines and workshops.Mr. Cheng Wan Wai, Founder, Chairman and CEO of Q P Group concluded: “The manufacturing industry is predicted to face a complicated economic landscape with both opportunities and challenges in 2025. The consumer market is expected to show resilience, underpinned by steady economic growth and declining inflation. In contrast, the imposition of tariffs and heightened protectionism driven by widespread geopolitical tensions will inevitably impact the manufacturing sector. Based on our solid business and financial foundation, we are confident about the long-term prospect of the Group. We will continuously implement appropriate strategies to sustain steady growth and create long-term value for our stakeholders.About Q P Group Holdings Limited (Stock code: 1412)Established in Hong Kong in 1985, Q P Group is one of the leading paper-based tabletop games and greeting cards manufacturers in the PRC, with production sites in Dongguan and Heshan in Guangdong Province and Phu Ly City in Ha Nam Province, Vietnam. Its principal product categories include tabletop games, greeting cards, trading cards, educational items and premium packaging. Since 2010, the Group has been operating web sales businesses to provide online solutions for diversified customised paper products and gift items. Currently, the number of its active registered users has reached over 77,600.Q P Group’s major websites are:www.makeplayingcards.comwww.boardgamesmaker.comwww.createjigsawpuzzles.comwww.printerstudio.comQ P Market Network:www.qpmarketnetwork.comFor more information, please visit: https://www.qpp.com/Media EnquiriesStrategic Financial Relations LimitedVicky LeeTel: (852) 2864 4834Email:vicky.lee@sprg.com.hkPhoebe LeungTel: (852) 2114 4172Email:phoebe.leung@sprg.com.hkWill ChengTel: (852) 2864 4894Email:will.cheng@sprg.com.hkWebsite: http://www.sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

香港, 2025年3月24日 - (亞太商訊 via SeaPRwire.com) - 「十四五」開篇以來，能源央企深入落實習近平總書記關於能源安全和綠色發展的一系列重要論述，統籌「保障能源安全」和「綠色低碳轉型」兩大任務，積極貫徹國家「雙碳」戰略，全力推動高質量發展。中國電力（02380）作為國家電投旗下清潔能源旗艦上市平台，是電力企業清潔轉型和高質量發展方面最具有代表性的上市公司之一。智通財經APP了解到，中國電力3月20日發佈2024年業績公告，並在3月21日召開業績發佈會。該公司全年實現收入542.13億元，同比增長22.48%，其中清潔能源收入322億元，佔總收入60%，同比提升了9個百分點。實現權益持有者應占利潤38.62億元，經營性淨利潤創上市以來歷史新高。合併裝機容量達到4939.1萬千瓦，其中清潔能源佔比80.12%。該公司計劃宣派2024年度股息人民幣0.162元/股，派息率60%；加上2024中期特別股息0.05元/股，全年派息總額0.212元/股，派息率達到78%，對應股息率超過7.7%。四年「翻一番」，能源轉型和業績增長全面提速2021年，中國電力發佈全新戰略，步入清潔發展和創新驅動的轉型快車道，清潔能源裝機佔比快速提升、資產質量持續優化、科技創新形成新的支撐，形成了清潔發展與科技創新「雙輪驅動」、水火風光協同互濟的發展格局。存量提質方面，成功對超600萬千瓦虧損煤電開展煤電聯營，快速堵住經營業績「出血點」，煤電板塊度電盈利能力已從行業中下游躍升至領先地位。從轉型的成效來看，2021年以來，該公司實現4年「翻一番」：合併裝機容量增加85%，資產總額增加118%，營業收入增長91%，歸母淨利潤增長126%。數據來源：公司財報聚焦科技創新與核心競爭力，紮實推進戰新產業發展2021年以來，中國電力科技創新全面提速，在新型儲能、儲能安全、新型電力系統建設關鍵技術等領域掌握了一批技術。在新型儲能領域，新源智儲已獲評北京市「獨角獸」，牽頭建設應急管理部電化學儲能安全重點實驗室，推出了「智儲-銀河」系列超分子全浸沒式工商業儲能一體機，從源頭上切斷了發生火災的可能性；在綠電交通領域，啟源芯動力市場佔有率保持行業領先，C輪融資投後估值達100億元；在清潔供暖和地熱領域，新源泰利建成房山區首個100%可再生能源供熱製冷項目，獲批共建地熱院士專家工作站。分紅金額逐年上升，以實際行動回饋股東2021-2024年，該公司每股派息從0.05元上升至0.162元，2021年利潤受到火電的影響而虧損，但該公司依舊堅持派息，2022年恢復盈利後，三年的平均派息比例超過60%。拉長周期看，根據東方Choice數據，2004年以來該公司累計派息21次，平均派息比例達56.91%，在業內處於領先水平。而在分紅的持續增長下，目前其股息率已具較大吸引力。數據來源：公司公告，2024年不包括特別股息高度重視資本市場，市值表現取得顯著突破2021年以來，中國電力密集開展資產結構調整、收購母公司資產、股權激勵、母公司增持、ESG管理、投資者關係等工作，在資本市場關注度逐漸提升。2021-2022年，中國電力股價上漲超過3倍，市值最高超過600億港幣，之後2年受大環境以及電力政策影響有所回撤。該公司管理層稱，將全面加強市值管理，落實國資委關於加強中央企業控股上市公司市值管理工作的各項意見，研究各項市值管理工具利用，加大重視股東回報。值得注意的是，該公司持續獲得各方看好：大股東國家電投近年持續開展增持；中信金融資產於2024年舉牌並獲得1名董事席位；而港股通資金也在持續流入，其中滬港通於最近60日淨買入1.62億股，截止3月21日持股比例13.78%，較2021年增長約10個百分點。此外，該公司也獲得多家境內外投行看好，給予目標價均顯著高於現價。綜合來看，「十四五」開篇至今，中國電力加速內功修煉，向市場交出了一份靚麗的成績單。在算力需求呈指數級增長導致全球開啟電力競賽的背景下，在能源政策支持電力企業高質量發展的趨勢下，電力公司在資本市場有望獲得估值回歸。而中國電力憑藉自身戰略、資產結構等差異化優勢，有望迎來更好的投資機會。 Copyright 2025 亞太商訊 via SeaPRwire.com.

SINGAPORE, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - The Korea Agro-Fisheries and Food Trade Corporation (aT) continues to champion the excellence of Korean produce in Singapore with its latest showcase — an exclusive event celebrating premium Korean rice and fruits. The event, held yesterday at The Butcher’s Dining, featured a live cooking demonstration and tasting session, offering attendees a firsthand experience of Korea’s finest agricultural products. The event was graced by the presence of Song Mi-Ryung, the Minister of Agriculture, Food and Rural Affairs of South Korea and Hong Jin-Wook, the Ambassador of the Republic of South Korea to Singapore.Clockwise from Top Left Image: Korean Culinary Masterclass Held at The Butcher's Dining, Minister Song Interacting with Masterclass guests, Korean Fresh Zone at CS Fresh at Great World City, Minister Song Browsing Products at the Korean Fresh ZoneSince its establishment in 1967, aT has played a pivotal role in promoting Korean food products worldwide, fostering deeper appreciation through strategic events and brand partnerships. With the growing demand for high-quality international produce in Singapore, aT aims to introduce more consumers to the unique textures, flavors, and versatility of Korean rice and fruits.Distinctive Korean FlavoursKorean cuisine is celebrated not only for its bold flavors but also for its numerous health benefits, thanks to its emphasis on fresh, nutrient-rich ingredients and time-honored culinary traditions. A cornerstone of Korean food is its use of fermented ingredients such as kimchi and doenjang (soybean paste), which are packed with probiotics that support gut health, improve digestion, and enhance overall well-being. These naturally fermented foods contribute to a balanced diet, aligning with the increasing consumer focus on digestive health and immune-boosting nutrition.Renowned for its chewy texture and exceptional quality, Korean rice has established itself as a distinctive staple in Singapore’s culinary landscape, setting it apart from varieties such as Thai jasmine rice and Vietnamese broken rice. Naturally gluten-free and rich in essential nutrients, Korean rice as well as rice products serves as the foundation for many beloved dishes, including bibimbap, tteokguk, and tteokbokki. Bibimbap stands out as a nutritionally balanced dish, featuring a vibrant medley of Korean vegetables that are high in fiber, vitamins, and antioxidants – key elements of a health-conscious diet. The focus on fresh, seasonal ingredients aligns with the growing global demand for healthier food choices, as reported by The Business Research Company, the functional foods market is projected to expand from $281.3 billion in 2024 to $315.1 billion in 2025, reflecting a robust compound annual growth rate (CAGR) of 12%.Beyond staple grains, Korean fruits such as Shine Muscat grapes and premium strawberries have gained international recognition for their exceptional sweetness and quality. Frequently used in both savory and dessert dishes, these fruits are not only a treat for the palate but also rich in antioxidants and vitamin C, further reinforcing the health benefits of Korean cuisine. As consumers worldwide increasingly prioritise immune-boosting foods, the demand for nutrient-dense Korean ingredients continues to rise.Premium K-Food Exhibition: A Display of Various Korean Rice Products as well as Other Korean ProduceAt the event, a stunning display of premium K-Food export products took center stage. From Korean rice and rice-based products to traditional liquors and premium fruits such as Korean strawberries and Shine Muscat grapes, the showcase offered a rich selection of Korea’s finest ingredients. A standout highlight was the introduction of 12 traditional Korean liquors, specially airlifted from Korea for this event. These liquors, many of which had never been exported to Singapore before, showcased the incredible diversity of Korean traditional brews, featuring unique ingredients such as plum, lingzhi, pine and yuzu, all crafted with a base of Korean rice.Adding to the excitement was the Baba Gimbap, a product that made waves after selling out in major U.S. retail stores in 2023. Visitors also had the chance to discover a variety of rice-based delicacies, including porridge, tteokbokki, and rice cakes.The fresh produce display corner was undoubtedly the centerpiece of the event. Featuring Korean-grown rice, renowned for its superior quality, alongside premium Korean strawberries and Shine Muscat grapes, the display highlighted some of Korea’s most coveted agricultural treasures. With their vibrant colors and pristine presentation, these premium ingredients created a stunning visual showcase, embodying the essence of luxury and excellence. Guests had the opportunity to explore these exquisite products up close, further deepening their appreciation for the richness of Korean fresh produce.A Culinary Showcase: Korean Ingredients in Everyday CookingThe event featured a live cooking demonstration led by esteemed culinary instructor Kim Hyuna, who guided attendees through the preparation of four signature dishes incorporating Korean ingredients, including premium rice and fruits:Bibimbap – A classic Korean mixed rice dish featuring a vibrant assortment of seasonal local and Korean vegetables and a rich, flavourful gochujang (red chili paste) sauce.Gungjung Tteokbokki – A royal court-style variation of the popular dish that showcases the diversity of tteokbokki by incorporating an assortment of vegetables. The combination of fresh ingredients and the chewy texture of tteok creates a harmonious blend of flavors.Tteokguk – Despite being a staple in Korean cuisine, tteokguk remains relatively unknown overseas. This dish is prepared by simmering beef until tender in a deeply flavourful broth and seasoned with a simple yet refined touch, tteokguk is the quintessential New Year’s dish, comforting, satisfying, and rich in cultural significance.Nurungji Ice Cream – A unique dessert crafted from nurungji (crispy scorched rice) and millet powder. Soft ice cream is paired with crunchy nurungji crackers and a dusting of warm millet powder, drawing inspiration from the Western affogato. Seasonal Korean strawberries or Shine Muscat grapes are added as toppings for a refreshing twist.Guests also had the opportunity to savour these dishes alongside traditional Korean wine pairings, enhancing their appreciation of the depth and complexity of Korean cuisine.A Commitment to Elevating Korean Produce in SingaporeSpeaking at the event, Song Mi-Ryung, Minister of Agriculture, Food and Rural Affairs of South Korea, remarked, “As we celebrate the 50th anniversary of diplomatic relations between South Korea and Singapore, we are deeply honored to host this event, showcasing the best of Korean cuisine in Singapore. We have carefully curated four special menus featuring premium Korean rice and rice products, fresh strawberries and shine muscat grapes, all grown in Korea’s distinct four seasons, paired with traditional liquors that perfectly complement each dish. We hope that many in Singapore will come to appreciate and enjoy these exceptional Korean ingredients, from rice-based delicacies to our vibrant fruits and time-honored liquors. This event reaffirms aT’s dedication to enhancing awareness and accessibility of Korean produce in Singapore. By showcasing the superior quality and versatility of Korean rice and berries, we aim to strengthen our presence in the market and inspire more consumers to embrace the rich and diverse flavors of Korea.”Korean Fresh Zone: Masterclasses and more at CS Fresh at Great World CityBuilding on the excitement around Korean fresh produce, aT, in partnership with CS Fresh at Great World City, will be hosting the Korean Fresh Zone Promotion from 20 to 26 March.Renowned chef Daren Teo – better known online as @thepantryboy – will be leading a series of exclusive masterclasses, showcasing the art of preparing iconic Korean dishes such as Japchae, Kimchi-jjigae, Boseot Jeongol and delectable Korean-inspired desserts like fruit tarts. With a background that includes training in France under a three-Michelin-starred chef and experience at the Michelin-starred restaurant Burnt Ends, Chef Daren will share expert techniques using the finest Korean fresh produce available at the Korean Fresh Zone in CS Fresh at Greeat World City, including over 40 varieties of vegetables and mushrooms, as well as premium Korean strawberries and Shine Muscat grapes. The masterclasses will be hosted by Eric Youn (@esyfilms), a beloved content creator known as the "Korean Oppa from Singapore”, attendees will get to sample some of the dishes and even stand a chance to win exclusive giveaways!Shoppers who spend $30 or more on Korean Fresh Zone produce, Korean strawberries or Shine Muscat grapes will receive a complimentary set of three chocolate-coated strawberries from chocolate boutique, BerryBar. Shoppers can choose from available designs in-store, while stocks last.Don't miss this exciting celebration of Korean flavors at CS Fresh!For more information on upcoming events and partnerships by aT, please visit www.at.or.kr.About the Korea Agro-Fisheries and Food Trade Corporation (aT)Established in 1967, the Korea Agro-Fisheries and Food Trade Corporation (aT) is a key government agency dedicated to advancing the global trade, export, and marketing of Korean foods and beverages. With a mission to elevate Korean agricultural products and culinary culture worldwide, aT leverages strategic partnerships and innovative strategies to promote Korean products while adapting to key trends, benefiting both producers and consumers. Copyright 2025 ACN Newswire via SeaPRwire.com.

TAIPING, Malaysia, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - This Hari Raya Aidilfitri, Spritzer invites Malaysians to celebrate the heart of the season by creating new, happy memories through simple, thoughtful acts of understanding and kindness. In conjunction with the 2025 Hari Raya celebrations, from 21st March to 20th April 2025, the Spritzer EcoPark has been freshly adorned, transforming it into a festive sanctuary where families and friends can come together, reconnect, and reflect.Photo 1: One of Spritzer EcoPark DecorationsSpritzer’s dazzling decorations feature a blend of classic Malay motifs with floral elements through seven unique setups. Many of the designs incorporate upcycled decorations, showcasing sustainability alongside artistry. One of the setups features a lush, flower-adorned bower that adds to the enchanting atmosphere. Moon and star elements, synonymous with Islam, are also woven throughout the designs. With intricate details and glowing elements, the decorations create a captivating experience that is just as stunning during the day as it is at night. Entry to the Spritzer EcoPark remains free for all!“Celebrations are about more than just coming together; it is about understanding and highlighting things that bring joy to our lives and loved ones. This year’s theme is about celebrates thoughtfulness through simple acts of kindness and care,” said Winnie Chin, Head of Public Relations of Spritzer. “At Spritzer, we believe that true celebration comes from thoughtful gestures, whether it is spending quality time, nourishing our families, or simply creating a space for everyone to enjoy nature at its best. Spritzer EcoPark was preserved for this purpose – a legacy where people can connect, reflect, and celebrate surrounded by the tranquillity of nature.”Photo 2: Spritzer EcoPark decorations with traditional Malay elementsSpritzer EcoPark offers a variety of engaging activities for all ages to add onto the festive atmosphere. Families can enjoy mini golf, paddle kart rides, and creative DIY crafts, making this celebration one of shared laughter and meaningful connections. The Snack Station provides delicious treats at affordable prices, while the Water Shop ensures that guests can stock up on Spritzer’s refreshing products and try out the new Spritzer Hari Raya recipes for their Raya gatherings. Unique souvenirs will also be available at the Souvenir Shop, allowing visitors to take home a special memento of their time at the park.Photo 3: Spritzer EcoPark Decorations at nightWishing you a joyous Hari Raya from Spritzer EcoPark! Whether you are here for fun, relaxation, or a refreshing escape, we are ready to make your celebration even more special.The park is open daily from 10:00 AM to 9:30 PM. We are located at Lot 898, Jalan Reservoir, Off Jalan Air Kuning, 34000 Taiping, Perak.For more updates and details, follow Spritzer EcoPark on Facebook and Instagram. – End–About SpritzerSpritzer, Malaysia’s No.1 bottled water brand since 1989, sources its water from a 430-acre tropical rainforest in Taiping. The water undergoes a natural filtration process through underground rocks for over 15 years, enriching it with essential minerals like Silica, which benefits skin, bones, hair, and nails.As a leader in smart manufacturing, we use advanced technology to ensure quality and safety. Our packaging is 100% recyclable and made from recycled materials, reflecting our commitment to sustainability. Tested annually by SIRIM, our products are free from microplastics.Spritzer offers a full range of products, from Natural Mineral Water and Sparkling Water to Distilled Water and Fruit-flavoured Beverages, catering to every lifestyle and occasion. With a vision to become a circular brand by 2030, we are committed to sustainability and delivering quality you can trust.Spritzer—nature, innovation, and sustainability in every bottle. For more information, please visit www.spritzer.com.my. Copyright 2025 ACN Newswire via SeaPRwire.com.

Key Highlights:Hiring activity in Singapore saw recovery with a 3% month-on-month growth while witnessing an annual dip of 5% in February’25Advertising, Public Relations & Media sector and the Education sector lead with 7% month-on-month growth in February '25Hiring for Software, Hardware, and Telecom roles record the highest growth at 2% month-on-month Legal sector saw the strongest annual growth at 19% year-on-yearSINGAPORE, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - foundit (formerly Monster APAC & ME), one of the leading jobs and talent platform, today published the foundit Insights Tracker (fit) Singapore for February 2025. The Singapore fit report highlights growth in the Advertising and Education sectors alongside rising demand for technology professionals.The tracker reveals an overall year-on-year (YoY) decline of 5% in hiring activity across sectors, as the index dropped from 108 in February 2024 to 103 in February 2025. However, a month-on-month (MoM) analysis indicates a 3% uptick,Commenting on Singapore's job trends for February 2025, V Suresh, CEO, foundit, said,“The February 2025 foundit Insights Tracker signals a promising recovery in Singapore’s job market. While year-on-year figures reflect ongoing economic recalibration, the month-on-month growth indicates a resurgence in hiring activity. The robust expansion of sectors such as Advertising, Media, and Education, coupled with the growing demand for technology professionals, underscores shifting industry priorities and workforce evolution. As digital transformation accelerates, Singapore’s job landscape is stabilizing, with a strong emphasis on upskilling, adaptability, and future-ready talent."Advertising, and Education sectors lead industry growth, while Engineering and Retail sectors show strong improvementsThe Advertising, Market Research, Public Relations, Media, and Entertainment sector has emerged as a frontrunner in e-recruitment activity among all monitored industries, showing a 7% MoM growth in February 2025. This growth is driven by increased digital marketing efforts and brand-building strategies.Equally impressive, the Education sector also recorded 7% MoM growth in February 2025, reflecting a continued emphasis on workforce upskilling and professional development.Following these leaders, the Engineering, Construction, and Real Estate sector showed positive trends with 6% MoM growth, while the Retail, Trade, and Logistics sector experienced 5% MoM growth, both driven by sustainability initiatives and evolving business needs.Several sectors show modest growth while others remain stableThe Production/Manufacturing, Automotive, and Ancillary sector demonstrated positive hiring momentum with 5% MoM growth in February 2025.Several sectors showed more modest growth, with Hospitality & Travel, IT, Telecom/ISP, and BPO/ITES, BFSI, and Healthcare all registering 2% MoM increases, signalling steady job creation across these industries.Conversely, multiple sectors including Oil and Gas, Import/Export, Shipping/Marine, Government/PSU/Defence, and Consumer Goods/FMCG exhibited stagnant hiring activity with 0% MoM change.Technology roles lead demand among functionsIn terms of functions, Software, Hardware, and Telecom witnessed the highest demand in February 2025, with a 2% MoM increase. This trend underscores the growing need for tech talent amid ongoing digital transformation initiatives.Marketing & Communications, HR & Admin, Engineering/Production, Sales & Business Development, Medical Roles, and Legal roles all showed modest but positive growth at 1% MoM, indicating broad but measured hiring activity across professional functions.The roles in Legal experienced a robust 19% YoY increase in hiring activity, highlighting the rising need for legal professionals amid evolving regulatory landscapes, corporate expansions, and compliance requirements.However, Hospitality Roles, Customer Service, Finance & Accounts, and Purchase/Logistics/Supply Chain roles saw no changes (0% MoM), reflecting a period of stability in workforce demand across these functions.The foundit Insights Tracker is a comprehensive monthly analysis of online job posting activity conducted by foundit. Based on a real-time review of millions of employer job opportunities culled from a large, representative selection of online career outlets, the foundit Insights Tracker (FIT) presents a snapshot of employer online recruitment activity nationwide.About foundit - APAC & Middle Eastfoundit, formerly Monster (APAC & ME), is Asia’s leading jobs and talent platform offering comprehensive employment solutions to recruiters and job seekers across APAC & ME. In addition to its innovative AI-powered job search, foundit offers e-learning, assessments, and services related to resume creation and interview preparation. foundit has connected over 120 million job seekers across 18 countries with the right job roles and upskilling opportunities. Over the last two decades, the company has been a leader in the world of recruitment solutions and has launched cutting-edge tools to give recruiters access to passive candidates in addition to active ones. With its advanced technology, foundit is efficiently bridging the talent gap across industry verticals, experience levels, and geographies.Today, foundit is committed to enabling and connecting the right talent with the right opportunities by harnessing the power of deep tech to sharpen hyper-personalised job searches and offer precision hiring. Additionally, foundit has been recognised as a Great Place to Work, reflecting its dedication to fostering a supportive and dynamic work culture.To learn more about, foundit in APAC & Gulf, visit: www.foundit.sg |www.foundit.com.ph | www.foundit.my | www.foundit.in | www.founditgulf.com | http://www.foundit.hk | www.foundit.id For media inquiries or further information, please contactNamrata Sharma – Namrata.sharma@adfactorspr.comContact number - +65 81383034 Copyright 2025 ACN Newswire via SeaPRwire.com.

- ComfortDelGro, a leading multi-modal mobility transport operator, introduces a new purpose statement to reflect its commitment to driving positive impact for a better future. - Refreshed logo and corporate identity underscores the company’s journey as a global, progressive, and collaborative mobility leader. SINGAPORE, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - ComfortDelGro Corporation Limited (SGX:C52) (“ComfortDelGro” or, “The Group”) today, unveiled its refreshed corporate brand, comprising a new purpose statement and modern visual identity that signifies a step forward in the company’s evolution into a global multi-modal transport leader. The Group has made significant strides in growing its international business, winning bus and rail tenders in Europe and Australia, as well as building leading positions for its point-to-point mobility businesses in key markets. With a presence in 13 countries, 24,500 employees, an operating fleet of over 54,000 vehicles and a rail network of 343 kilometres in operation and under mobilisation, ComfortDelGro is one of the largest land transport companies in the world. ComfortDelGro Managing Director/Group CEO Cheng Siak Kian said, “Our purpose statement – Mobility for a better future, drives us to reimagine mobility as a catalyst for positive impact as we accelerate our growth and navigate new horizons. It reflects our commitment to addressing the changing needs of our stakeholders as a global multi-modal transport leader. At the same time, it aligns the Group’s diverse operations and workforce under the common goal of building a purpose-driven and values-led organisation.” ComfortDelGro Chairman Mark Greaves added, “The transport landscape is evolving, and so is ComfortDelGro. We are committed to sustainable mobility, powered by innovation and driven by collaboration. This brand refresh underpins our journey forward as a global, progressive, and collaborative mobility company while building on the strong foundation of our businesses and our rich heritage. Our purpose ‘Mobility for a better future’ will guide us as we continue to create long-term value for our stakeholders, shape the future of transportation, and contribute to a more sustainable and connected world." Driven by our new purpose: Mobility for a better futureA modern identityComplementing our purpose statement is an updated ComfortDelGro logo that symbolises the company’s journey forward and its commitment to delivering innovative, world-class mobility solutions. Key elements include:A refined blue hue, representing reliability, trust, and customer confidence.A streamlined lowercase font, conveying approachability and collaboration.An enhanced arrow motif, reinforcing the company’s forward-thinking and dynamic approach.The updated brand and corporate identity will be gradually implemented in stages across the Group’s global operations.Media Assets:High-resolution images can be downloaded here: https://fromsmash.com/cdgbrandrefreshAbout ComfortDelGro CorporationComfortDelGro is a leading multi-modal transport operator offering a comprehensive suite of transportation solutions. Our extensive network spans public transport including buses and rail, point-to-point transport with taxis and private hire cars as well as business-to-business mobility solutions. Every day, millions rely on our services across 13 countries including; Singapore, Australia, the United Kingdom, New Zealand, China, Ireland, Sweden, France, Malaysia, Spain, Portugal, Greece, and the Netherlands. As a global operator, we play an important role in steering the transition towards a low-carbon economy. With about 60% of our owned fleet consisting of cleaner energy vehicles, we support governments and cities in enabling inclusive and sustainable transport systems. For our efforts, ComfortDelGro has been included in the Dow Jones Best-in-Class Indices since 2019, the only Singaporean transport company in the index. Media Contact Information:Group Corporate Communications ComfortDelGro Corporation Limited groupcorpcomms@comfortdelgro.com Copyright 2025 ACN Newswire via SeaPRwire.com.

Financial Highlights For the Year Ended 31 December RMB20242023Change RMB’BillionRMB’Billion(%)Revenue28.8726.20+10.2%Gross profit margin (%)81.5%81.0%+0.5pptSelling and administrative expenses to revenue ratio (%) *42.1%42.2%-0.1pptR&D expenses to revenue ratio (%)17.6%16.8%+0.8pptProfit for the year6.365.10+24.9%Profit attributable to owners of the parent **3.502.33+50.1%Adjusted non-HKFRS profit attributable tothe owners of the parent *** 3.46 2.59 +33.5%Basic earnings per share, based on adjusted non-HKFRS profit attributable to the owner of the parent (RMB cents) 18.90 13.97 +35.3%Sales of innovative products ****12.069.89+21.9%Share of revenue (%)41.8%37.8% Sales of new products*****10.098.05+25.4%Share of revenue (%)35.0%30.7% Dividend per share (HK cents)7.05.0+40.0%- Interim3.02.0+50.0%- Final4.03.0+33.3%*The total of selling and distribution costs and administrative expenses divided by revenue**The significant year-on-year increase in profit attributable to the owners of the parent was mainly driven by the notable growth in revenue and the gain on disposal of subsidiaries during the year***It refers to the basic earnings attributable to the owners of the parent after excluding impacts of discontinued operations, certain non-cash items and the share of profits and losses of associates and joint ventures.****Sales is the gross sales amount minus the sales discount. Innovative products include innovative drugs and biosimilars*****Products launched within five yearsDevelopment HighlightsOncology Innovative Drugs- Focus V (Anlotinib Hydrochloride Capsules) has been approved for seven indications. The marketing applications of three new indications have been submitted to the Center for Drug Evaluation of the China National Medical Products Administration (“CDE”), while another three pivotal clinical trials for new indications have shown positive results. The Group will submit new marketing applications to the CDE for these indications in the near future. In addition, anlotinib is in Phase III clinical studies for a number of new indications, including first-line non-squamous non-small cell lung cancer and first-line colorectal cancer. It is expected that marketing applications will be submitted gradually in the next few years.- Yilishu (Efbemalenograstim alfa Injection) has completed three global multi-center, randomized, and controlled pivotal Phase III clinical trials, and has been compared with the commonly used short-acting and long-acting G-CSF drugs in clinical practice, proving its efficacy and safety. In December 2023, Efbemalenograstim alfa was successfully included in the NRDL, and its sales volume accelerated in 2024, becoming an important contributor to the Group’s revenue growth.- Anfangning (Garsorasib Tablets) is a novel and highly effective KRAS G12C inhibitor that was approved for marketing by the NMPA in November 2024 for the treatment of advanced non-small cell lung cancer with KRAS G12C mutation that has received at least one systemic treatment. The Group will further explore the multi-indication potential of garsorasib, which is expected to become another blockbuster product in the oncology field.- Anbeisi (Bevacizumab Injection), Delituo (Rituximab Injection), Saituo (Trastuzumab for Injection), and Paletan (Pertuzumab Injection) were approved for marketing by the NMPA in February 2023, May 2023, July 2023, and December 2024, respectively. The rapid increase in the volume of these biosimilars in 2024 has accelerated the Group’s revenue growth.Liver Disease Innovative Drugs- Tianqing Ganmei (Magnesium Isoglycyrrhizinate Injection) is the fourth-generation of glycyrrhizic acid preparation that has been approved for three indications: chronic viral hepatitis, acute drug-induced liver injury, and improvement of liver dysfunction. Magnesium isoglycyrrhizinate is the world’s first 99.9% purified alpha-glycyrrhizic acid. It has the advantages of strong liver targeting, excellent anti-inflammatory effects, and good safety.- Lanifibranor (pan-PPAR agonist) is currently undergoing Phase III clinical trials worldwide for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). In July 2023, Lanifibranor was granted Breakthrough Therapy Designation by the CDE. Lanifibranor is China’s first MASH drug to enter Phase III clinical trials and is expected to fill the gap in China’s MASH market.Respiratory Innovative Drugs- Tianqing Suchang (Budesonide Suspension for Inhalation) is China’s first budesonide nebulized generic drug approved for marketing, breaking the long-term monopoly of branded drugs in the domestic market, and offering an effective, safe and economical high-end product for patients with chronic airway inflammation in China. The product has been included in the national Volume-based Procurement (“VBP”). The Group has taken a series of proactive management measures in a timely manner, including strengthening downstream channels, expanding market coverage and conducting secondary development in markets outside the scope of the VBP, enabling its sales to achieve steady growth in 2024.- Tianyun (Colistimethate Sodium for Injection) is a first-to-market generic drug launched in 2021. It is China’s first colistimethate sodium for injection approved for marketing, and was successfully included in the NRDL in 2023. At present, only two products with the same generic name have been approved in China. The Group continued to expand its market coverage through active academic promotion, and Tianyun’s sales grew rapidly in 2024.Surgery/Analgesia Innovative Drugs- Zepolas (Flurbiprofen Cataplasms) is the first domestically produced cataplasms approved for marketing in China, ranking first in the market share of topical analgesia for many years. Sales of flurbiprofen cataplasms have maintained a growth trend in recent years and achieved breakthrough growth in 2024. The second-generation flurbiprofen patch developed by the Group is expected to be approved for marketing in 2025.Others- In 2024, the tenth batch of VBP products accounted for only 1% of the Group’s total revenue, and the related risks have basically been removed. In addition, Anboni (Unecritinib Fumarate Capsules) and Anluoqing (Envonalkib Citrate Capsules), two category 1 innovative drugs independently developed by the Group, were newly included in the NRDL and are expected to benefit more patients.HONG KONG, Mar 21, 2025 - (ACN Newswire via SeaPRwire.com) - Sino Biopharmaceutical Limited (“Sino Biopharm” or the “Company”, together with its subsidiaries, the “Group”) (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2024.During the year, the Group recorded revenue of approximately RMB28.87 billion, an increase of approximately 10.2% over last year. Profit attributable to the owners of the parent company was approximately RMB3.50 billion, a substantial increase of approximately 50.1% over last year. Earnings per share attributable to the owners of the parent company were approximately RMB19.13 cents, a significant increase of approximately 51.9% over last year, which was mainly driven by the notable growth in revenue and the gain on disposal of subsidiaries during the year. Excluding the profit attributable to the owners of the parent from the discontinued operations, the share of profits and losses of associates and joint ventures (net of related tax and non-controlling interests), one-off adjustments for the impairment and fair value changes of certain assets and liabilities (net of related tax and non-controlling interests), fair value losses/(gains) of current equity investments (net of related tax and non-controlling interests), share-based payments (net of related tax and non-controlling interests), effective interest expenses and exchange (gain)/loss of the convertible bond debt component, adjusted non-HKFRS profit attributable to the owners of the parent was approximately RMB3.46 billion, an increase of approximately 33.5% over last year. The Group's liquidity remains strong, with total fund reserve at approximately RMB24.11 billion, including cash and bank balances classified under current assets of approximately RMB9.57 billion, bank deposit classified under non-current assets of approximately RMB9.37 billion, and the wealth management products of approximately RMB5.17 billion in aggregate.The Board of Directors has recommended a final dividend payment of HK4 cents per share (2023: HK3 cents). Together with the interim dividend of HK3 cents already paid, the total dividend for the year amounted to HK7 cents (2023: HK5 cents).Sales: Robust sales system continues to drive results Achieves positive revenue growth for generic drugsOn the strong foundation its generic drug business provides, the Group has comprehensively promoted innovation and transformation. The innovative products have kept boosting sales growth, with share of revenue climbing year after year. Revenue from innovative products amounted to RMB12.06 billion, up by 21.9% year-on-year, and accounted for 41.8% of the Group's total revenue.During the year, the sales of oncology medicines amounted to approximately RMB10.73 billion, representing approximately 37.2% of the Group’s revenue. The sales of surgery/analgesia and liver disease amounted to approximately RMB4.46 billion and RMB3.44 billion, respectively, representing approximately 15.4% and 11.9% of the Group's revenue, respectively. In addition, sales contributions from various areas such as respiratory, cardio-cerebral vascular medicines and others have continued to contribute to the Group's revenue. Among them, the sales of respiratory and cardio-cerebral vascular medicines accounted for approximately 10.9% and 7.5% of the Group's revenue, respectively.R&D: Pushes at full force innovative product development Actively applies for various patentsThe Group has continued to focus its R&D efforts on new medicines in the four therapeutic areas of oncology, liver diseases, respiratory and surgery/analgesia. As at the end of the reporting period, the Group had 70 innovative products under development, including 39 oncology products, 7 liver disease products, 13 respiratory products, and 6 surgery/analgesia products, and 5 other products. In addition, the Group had 65 generic drug products in development.The Group also attaches tremendous importance to the protection of intellectual property rights and encourages its member enterprises to file patent applications in order to enhance the Group’s core competitiveness. During the reporting period, the Group filed 1,069 new patent applications and received 349 patent invention approvals. As at the end of the reporting period, the Group had accumulated 5,082 effective patents and patent applications and obtained 1,958 patent invention approvals.Prospects: Focuses on core business and innovation Continues to promote dual-pronged approach in implementing globalization strategyThe Chinese pharmaceutical market has occupied a key position in the global pharmaceutical industry due to its huge volume and increasing market demand. In addition, as a strategic industry closely linked to the national economy and people’s livelihood, the pharmaceutical industry receives key support from national policies and incentives. Meanwhile, a series of policies is expected to broaden the pricing flexibility of innovative drugs, improve their accessibility, and create a wider market prospect for such drugs.Committed to its vision “to be a leading global pharmaceutical company through delivering innovative therapies for patients”, the Group has adhered to comprehensive innovation, stepped up its R&D investment, and continued to strengthen its internal R&D capabilities. It has now built a comprehensive pipeline and product portfolio. At the same time, the Group has vigorously promoted business development and strategic cooperation, striving to become the best partner for global pharmaceutical and biotechnology enterprises.At present, the Group has entered the harvest period of its innovative development. It is expected that by 2027, the number of innovative products launched to the market will exceed 30, with revenue from innovative products accounting for over 55% of total revenue. This will further strengthen the Group’s dominant position in the four main therapeutic areas and provide strong impetus for the future sustainable growth. In addition, the Group has advanced its digitalization strategy with artificial intelligence (AI) as the core driving force. It has finished locally deploying cutting-edge AI models including DeepSeek and ChatGPT, and optimized key business such as cross-departmental collaboration, thereby significantly improving operational efficiency.Meanwhile, the Group adopts its dual-pronged globalization strategy to accelerate innovation and development. The Group will bring global pharmaceutical innovations to China to benefit Chinese patients, while also expanding its presence in international markets to target unmet clinical needs worldwide.Looking ahead, the Group will further focus on its core business and innovation, and continue to improve R&D efficiency and quality in the four major therapeutic areas. It will also actively accelerate the deployment for globalization of its business to drive rapid business growth and steady performance improvement, and contribute to the development of the global pharmaceutical industry.About Sino Biopharmaceutical Limited (HKEX:1177)Sino Biopharmaceutical Limited is a leading Chinese pharmaceutical company continuing to invest in Oncology, Liver Diseases, Respiratory and Surgery/Analgesia, exploring innovative therapies to improve the lives of patients. The company has strong manufacturing capabilities and broad patient access across China. Sino Biopharmaceutical Limited is committed to bring innovation to address unmet healthcare needs globally. The company was listed on the Hong Kong Stock Exchange in 2000, and was selected as a component of the MSCI Global Standard Index in China in 2013; In 2018, it was selected as a constituent stock of Hang Seng Index; In 2020, it was selected as a constituent stock of Hang Seng Connect Biotech 50 Index and the Hang Seng China (Hong Kong Listed) 25 Index. The company has been listed in the “Top 50 Global Pharmaceutical Enterprises” published by the authoritative American magazine Pharmaceutical Manager for six consecutive years, and has been rated as the “Top 50 Best Companies in Asia Pacific” by Forbes (Asia) for three consecutive years.For more information, please visit: www.sinobiopharm.com Copyright 2025 ACN Newswire via SeaPRwire.com.

SAN DIEGO, CA, Mar 21, 2025 - (ACN Newswire via SeaPRwire.com) - General Atomics Aeronautical Systems, Inc. (GA-ASI), a world leader in unmanned aircraft systems (UAS), has received the prestigious EMAR/FR 145 Maintenance Organization Approval for component maintenance from the French Military Continuing Airworthiness Authority, DSAE. This approval underscores GA-ASI's commitment to the highest standards of safety, compliance, and operational excellence in military aviation.The EMAR framework is a set of regulations developed from commercial aerospace standards (FAA/EASA) that are designed to ensure airworthiness for European military aircraft. It establishes a common airworthiness framework recognized by military airworthiness authorities worldwide. EMAR/FR 145 certification authorizes maintenance organizations to perform critical maintenance tasks while ensuring strict adherence to safety, reliability, and documentation requirements.GA-ASI's EMAR/FR 145 approval allows the company to issue EMAR Form 1s (Return to Service forms) for components serviced by the approved maintenance organization, confirming the safety and airworthiness of the equipment. This recognition applies to GA-ASI's maintenance activities at its Poway and Adelanto, California, facilities and covers CAT C (component maintenance) services."This approval is a significant achievement for GA-ASI, positioning the company to better serve international customers, especially military users of our MQ-9A and MQ-9B UAS platforms," said Sam Richardson, GA-ASI vice president of Sustainment. "The ability to leverage the EMAR/FR 145 certification streamlines the company's processes, reduces costs, and accelerates future airworthiness pursuits, as many future customers will recognize this certification rather than requiring a full, independent certification process."By obtaining EMAR/FR 145 approval, GA-ASI further demonstrates its ability to meet the stringent demands of the global defense market. The framework's widespread recognition ensures that GA-ASI can expand operations and offer high-quality, compliant maintenance services to international customers, ultimately driving company growth in global markets.This certification offers significant operational and financial benefits for both GA-ASI and its customers. For GA-ASI, the approval reduces future oversight costs by leveraging the DSAE Audit Team's oversight activities, ensuring a more efficient and cost-effective certification process for future non-French EMAR customers. For customers, the EMAR/FR 145 approval provides a framework recognized internationally, offering a streamlined maintenance certification process. The recognition agreements between EMAR and non-EMAR countries allow future customers to leverage GA-ASI's French approval, saving time and resources compared to a full certification effort.About GA-ASIGeneral Atomics Aeronautical Systems, Inc. is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 8 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle® 25M, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.